Overexpression of microRNA-155 predicts poor prognosis in glioma patients

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  Sun, Jun ^a   Shi, Huachao ^a   Lai, Niansheng ^a   Liao, Keman ^a   Zhang, Shuai ^a   Lu, Xiaojie ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Expression; Glioma; MicroRNA 155; Overall survival; Prognosis; Progression free survival

Indexed keywords

MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; AGE; ARTICLE; BRAIN TISSUE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; ADOLESCENT; AGED; APOPTOSIS; BRAIN; BRAIN TUMOR; DISEASE COURSE; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; TUMOR INVASION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84895778013     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0911-x     Document Type: Article

References (22)

1. Li M, Li J, Liu L, Li W, Yang Y, Yuan J. MicroRNA in Human Glioma. Cancers (Basel). 2013;5(4):1306-31. doi: 10.3390/cancers5041306.
2. Nakazato Y. The 4th edition of WHO classification of tumours of the central nervous system published in 2007. No Shinkei Geka. 2008;36(6):473-91.
3. Bregy A, Wong TM, Shah AH, Goldberg JM, Komotar RJ. Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme. Cancer Treat Rev. 2013;39(8):891-907. doi: 10.1016/j.ctrv.2013.05.007.
4. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842-50. doi: 10.1001/jama.2013.280319.
5. Stepniewski J, Jozkowicz A, Dulak J. Roles of microRNA in cell reprogramming. Postepy Biochem. 2013;59(2):157-63.
6. Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell. 2013;153(3):516-9. doi: 10.1016/j.cell.2013.04.003.
7. Chou J, Shahi P, Werb Z. microRNA-mediated regulation of the tumor microenvironment. Cell Cycle. 2013;12(20):3262-71. doi: 10.4161/cc.26087.
8. Uchino K, Ochiya T, Takeshita F. RNAi therapeutics and applications of microRNAs in cancer treatment. Jpn J Clin Oncol. 2013;43(6):596-607. doi: 10.1093/jjco/hyt052.
9. Chen Z, Ma T, Huang C, Hu T, Li J. The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol. 2013. doi: 10.1002/jcp.24492.
10. Onyeagucha BC, Mercado-Pimentel ME, Hutchison J, Flemington EK, Nelson MA. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp Cell Res. 2013;319(13):2081-90. doi: 10.1016/j.yexcr.2013. 05.009.
11. Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, et al. MiR-155-mediated loss of C/EBPbeta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene. 2013;32(50):5614-24. doi: 10.1038/onc.2013.322.
12. Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49(3):604-15. doi: 10.1016/j.ejca.2012.09. 031.
13. Liu Q, Chen J, Wang J, Amos C, Killary AM, Sen S, et al. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog. 2013;. doi: 10.1002/mc.22023.
14. Li CL, Nie H, Wang M, Su LP, Li JF, Yu YY, et al. Microrna-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncol Rep. 2012;27(6):1960-6. doi: 10.3892/or.2012.1719.
15. Levati L, Pagani E, Romani S, Castiglia D, Piccinni E, Covaciu C, et al. MicroRNA-155 targets the SKI gene in human melanoma cell lines. Pigment Cell Melanoma Res. 2011;24(3):538-50. doi: 10.1111/j.1755-148X.2011.00857.x.
16. Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett. 2013;587(9):1434-9. doi: 10.1016/j.febslet.2013.03.023.
17. Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang HT, et al. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol Rep. 2013;30(5):2111-8. doi: 10.3892/or.2013.2685.
18. Yu J, Cai X, He J, Zhao W, Wang Q, Liu B. Microarray-based analysis of gene regulation by transcription factors and microRNAs in glioma. Neurol Sci. 2013;34(8):1283-9. doi: 10.1007/s10072-012-1228-1.
19. Cobbs CS, Whisenhunt TR, Wesemann DR, Harkins LE, Van Meir EG, Samanta M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003;63(24):8670-3.
20. D'Urso PI, D'Urso OF, Storelli C, Mallardo M, Gianfreda CD, Montinaro A, et al. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int J Oncol. 2012;41(1):228-34. doi: 10.3892/ijo.2012.1420.
21. Poltronieri P, D'Urso PI, Mezzolla V, D'Urso OF. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours. Chem Biol Drug Des. 2013;81(1):79-84. doi: 10.1111/cbdd.12002.
22. Meng W, Jiang L, Lu L, Hu H, Yu H, Ding D, et al. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis. Cell Biol Int. 2012;36(7):653-9. doi: 10.1042/cbi20100918.